Refine
Year of publication
Document Type
- Article (43)
- Doctoral Thesis (22)
Language
- English (65) (remove)
Has Fulltext
- yes (65)
Is part of the Bibliography
- no (65)
Keywords
- - (38)
- Streptococcus pneumoniae (5)
- proteomics (4)
- Pneumokokken (3)
- <i>Staphylococcus aureus</i> (2)
- Arxula adeninivorans (2)
- Hyperuricemia (2)
- PspC (2)
- Virulenz (2)
- Yeast (2)
Institute
- Institut für Mikrobiologie - Abteilung für Genetik & Biochemie (65) (remove)
Publisher
- Frontiers Media S.A. (20)
- MDPI (14)
- S. Karger AG (3)
- American Society for Microbiology (ASM) (1)
- Nature Publishing Group (1)
- Public Library of Science (PLoS) (1)
- Wiley (1)
Genome-wide responses and regulatory mechanisms to thiol-specific electrophiles in Bacillus subtilis
(2008)
The soil-dwelling bacterium Bacillus subtilis is regarded as model organism for functional genomic research of low GC Gram-positive bacteria. Recently, the group of Haike Antelmann has monitored the expression profile of B. subtilis after exposure to phenolic compounds. Interestingly, proteome and transcriptome analyses showed a strong overlap in the expression profile after exposure to catechol, MHQ that auto-oxidized to quinones and the thiol-reactive electrophile diamide. The response to electrophilic quinones and diamide is governed by a complex network of transcription factors, including Spx, CtsR, PerR, CymR and the novel MarR-type repressors MhqR (YkvE), YodB and YvaP. The regulatory mechanisms of these novel thiol-stress sensors YodB and YvaP are studied as part of this thesis in collaboration with the group of Peter Zuber (Oregon). YodB negatively regulates the expression of the nitroreductase YodC and the azoreductase YocJ (AzoR1) after exposure to electrophilic quinones and diamide. The azoreductase AzoR1 is a paralog of AzoR2 that is under control of MhqR. Both paralogous azoreductases (AzoR1 and AzoR2) have common functions in quinone and azo-compound reduction to protect cells against the thiol reactivity of electrophiles. DNA binding activity of YodB is directly inhibited by thiol-reactive compounds in vitro. Mass spectrometry approaches suggested that YodB is regulated by a thiol-(S)-alkylation mechanism in response to quinones. Mutational analyses revealed that the conserved Cys6 residue of YodB is required for optimal repression in vivo and in vitro. Recent studies further suggest that YodB is redox-regulated by intersubunit disulfide formation in vivo by diamide. In addition to the azoreductases, several thiol-dependent dioxygenases confer resistance to quinones. In collaboration with Kazuo Kobayashi (Nara), the YodB-paralogous MarR/DUF24-family regulator, YvaP was identified as repressor of the catechol-2,3-dioxygenase encoding yfiDE (catDE) operon. DNA binding activity of YvaP was also directly inhibited by quinones and diamide in vitro indicating that also YvaP is regulated via post-translational modifications. Mutational analyses showed that the conserved Cys7 is essential for YvaP regulation in vivo and serves as sensor for thiol-reactive compounds. In addition, also the basic amino acids K19, R20 are essential for YvaP repression in vivo as well as conserved basic arginine and lysine residues located in the DNA binding helix-turn-helix (HTH) motif. Non-reducing PAGE analysis suggests the formation of an intersubunit disulfide bond in a YvaP dimer upon treatment with quinones and diamide in vitro. Besides quinones, also aldehydes are electrophilic compounds which react via the thiol-(S)-alkylation reaction with thiols. Thus, we were also interested in the response of B. subtilis to the toxic electrophiles methylglyoxal (MG) and formaldehyde (FA). We analyzed the changes in the transcriptome and proteome of B. subtilis after exposure to MG and FA. Like quinone compounds, both MG and FA induce the thiol-specific stress response. Metabolomic approaches confirmed that these reactive aldehydes deplete the cellular thiol pool and thus act like quinones as another class of thiol-reactive electrophiles. Additionally, MG and FA also triggered responses to overcome DNA damage. Our studies further revealed the specific induction of two FA detoxification pathways regulated by the MarR/DUF24 family repressor HxlR, and the novel MerR/NmlR-type regulator YraB (AdhR). HxlR positively regulates the hxlAB operon encoding the ribulose monophosphate pathway. AdhR positively regulates an adhA-yraA operon that encodes the thiol-dependent formaldehyde dehydrogenase (AdhA) and the DJ1/PfpI-like cysteine proteinase (YraA), and the yraC gene that encodes a γ-carboxymuconolactone decarboxylase. Thus, the AdhR regulon is involved in the detoxification of FA to formate via the formaldehyde dehydrogenase AdhA which catalyzes the cleavage of S-hydroxymethylcysteine adducts. In addition, the cysteine proteinase YraA could be involved in the degradation of S-hydroxymethylcysteine-modified and damaged protein thiols. In collaboration with the group of John Helmann (Ithaca), it was shown that AdhR binds in vitro to a conserved inverted repeat between the -10 and -35 promoter elements upstream of adhA, yraB and yraC. In addition, we showed that the conserved Cys52 of AdhR is essential for aldehyde sensing and activation of adhA-yraA transcription in vivo. Thus, we speculate that redox regulation of AdhR involves thiol-(S)-alkylation of this Cys52 residue by aldehydes as another novel mechanism of bacterial physiology.
Influence of single amino acid polymorphisms on the in vitro convertibility of goat prion protein
(2010)
Prion diseases or transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative disorders which include, among others, scrapie and bovine spongiform encephalopathy (BSE). The causative agent is composed mainly of a misfolded isoform of a cellular prion protein (PrPC), denoted prion protein scrapie (PrPSc). Genetically determined PrPC polymorphisms can modulate the convertibility of PrPC to PrPSc and thus lead to prolonged TSE incubation times or even complete resistance of the animal. In sheep, such polymorphisms are located at codons 136, 154 and 171. Several disease-associated amino acid polymorphisms also exist in caprine PrPC. However, due to their large number and the limited number of goats carrying them, it is difficult to assess their specific impact on TSE susceptibility in vivo. The susceptibility can be simulated in vitro by a cell-free conversion assay, in which the conversion efficiency of recombinant PrPC is determined. In this study, twelve caprine PrPC variants (M112T, M137I, L141F, I142M, H143R, N146S, N146D, R151H, R211Q, Q215R, Q222K and wild-type PrPC (denoted INRQ) were produced by using PCR mutagenesis amplification and expressed in E. coli M15 cells and purified on Ni-NTA agarose columns. The renatured PrPC variants had molecular masses of approx. 23 kDa and the expected conformation as determined by CD spectroscopy. These variants were then subjected to a cell-free conversion assay using different BSE and scrapie strains. Cross species (mouse and goat) cell-free conversion studies were performed and specific monoclonal antibodies were used to discriminate the exogenous PrPSc molecules used to seed the reaction and newly converted PrPres. The studies with the mouse-adapted strain Me7 revealed that polymorphisms M137I, H143R and L141F did not influence the conversion of PrPC in a significant manner. However, the reduced conversion rate of the variant I142M (harbouring a methionine at position 142 instead of isoleucine) correlated with longer scrapie incubation times in goats with this polymorphism. The polymorphisms M112T, R151H and Q211R showed also reduced conversion rates in comparison to INRQ, an effect that related well to reduced scrapie susceptibility of such goats in vivo. Polymorphisms N146S, N146D and Q222K were to date extremely rarely found in scrapie affected goats. It was intriguing to see that these amino acid substitutions also abolished the in vitro conversion efficiency completely as did the Q215R polymorphism, which had not yet been associated with scrapie resistance in vivo. Results of cell free conversion studies with mouse adapted BSE prions (BSE/Bl6 strain) correlated well with the results obtained with Me7, although the results with BSE/Bl6 showed more variation. Again it was possible to observe a reduction in the conversion with I142M, R151H and R211Q and no or almost no conversion with N146S, N146D and Q222K and with Q215R respectively. In subsequent experiments, caprine PrPC variants were directly biotinylated so that goat or sheep scrapie as well as cattle, sheep or goat BSE derived PrPSc could be used. In these assays I142M, H143R and R211Q clearly reduced the conversion of PrPC with ovine and caprine scrapie isolates, whereas R151H did not influence the conversion efficiency of biotin-tagged PrPC. Conversion with scrapie isolates showed a marked reduction or no conversion in the case of N146S and N146D which correlated again with the Me7 data and the in vivo observations. In the case of bovine BSE isolates, the cell-free conversion mimicked the species barrier observed in vivo. BSE material from cattle barely converted any caprine PrPC variant into PrPres, whereas BSE from sheep converted all variants including the resistance-associated N146S and N146D, suggesting that the resistance is also prion strain specific. A marked reduction in the conversion rate was also observed with I142M and, less pronounced, with H143R and R211Q corroborating the protective role of these polymorphisms against TSEs. When co-incubated, resistance-associated variants N146D, N146S and Q222K produced a dominant negative effect on the conversion of the susceptible wild-type PrPC genotype (INRQ). In a similar way, the incubation of I142M and H143R also reduced the amount of PrPres in a mixture with INRQ. In conclusion, the cell-free conversion assay results show that the caprine PrP polymorphisms M112T, I142M, R143H, N146S, N146D, R151H, R215Q and Q222K correlated clearly with the in vivo susceptibilities of the goats carrying these polymorphisms. Apart from practical implications, like the possibility of breeding TSE resistant goats, these data indicate that scrapie resistance is modulated by thermodynamic changes affecting PrPC-PrPSc interactions and the formation of conversion intermediates.
Hantaviruses (family Bunyaviridae) are enveloped viruses with a segmented RNA genome of negative polarity. They can cause two different diseases in humans, the hemorrhagic fever with renal syndrome in Europe and Asia and the hantavirus cardiopulmonary syndrome in America. The transmission to humans is mainly indirect by inhalation of aerosolized virus-contaminated rodent excreta. In contrast to the initial assumption that hantaviruses are mainly carried by rodents, during the last years many novel hantaviruses were detected in shrews, moles and recently in bats. These findings raise important questions about the evolutionary history of hantaviruses, their host association and adaptation, the role and frequency of spillover infections and host switch events. This study aims to prove the presence, geographical distribution and host association of the rodent-borne Tula virus (TULV) and the shrew-associated Seewis virus (SWSV) in Central Europe. For this purpose, novel laboratory techniques for molecular and serological hantavirus detection were developed. Initially, a broad-spectrum molecular assay to identify small mammal species from Central Europe was developed. This novel assay is based on PCR amplification using degenerated primers targeting the cytochrome b (cyt b) gene, nucleotide sequence analysis of the amplified cyt b gene portion and followed by pairwise sequence comparison to published sequences using the BLAST function of GenBank. Different small mammal species prevalent in Central Europe could be determined by this new approach, including not only representatives of various Rodentia and Soricomorpha, but also representatives of the orders Erinaceomorpha, Lagomorpha, Carnivora and Chiroptera. For characterization of insectivore-borne hantavirus Thottapalayam virus (TPMV), specific monoclonal antibodies were generated that detect native virus in infected mammalian cells. For the detection of TPMV-specific antibodies, Asian house shrew Suncus murinus immunoglobulin G (IgG)-specific antibodies were produced in laboratory mice and rabbit. Using this anti-shrew IgG and recombinant TPMV nucleocapsid (N) protein, an indirect enzyme-linked immunosorbent assay (ELISA) was developed allowing the detection of TPMV N protein-specific antibodies in immunized and experimentally TPMV infected shrews. A Pan-Hantavirus SYBR-Green RT-qPCR was developed for the search to novel hantaviruses. By this novel RT-qPCR and other conventional RT-PCR approaches, TULV infections were identified for the first time in the Eurasian water vole Arvicola amphibius from different regions in Germany and Switzerland. The phylogenetic analyses of the different partial TULV small (S)-, medium (M)- and large (L)-genome segment sequences from A. amphibius, with those of Microtus arvalis- and M. agrestis-derived TULV lineages, revealed a geographical, but host-independent clustering and may suggest multiple TULV spillover or a potential host switch from M. arvalis or M. agrestis to A. amphibius. In a further comprehensive study, different shrew species (Sorex araneus, S. minutus, S. coronatus, and S. alpinus) were collected in Germany, Czech Republic, and Slovakia and screened by another L-segment-targeting Pan-Hantavirus RT-PCR approach. This screening revealed hantavirus L-segment sequences in a large number of S. araneus and a few S. minutus indicating a broad geographical distribution of this hantavirus. For detailed analyses, S-segment sequences were obtained, from S. araneus and S. minutus. The sequences demonstrated their similarity to SWSV sequences from Hungary, Finland, Austria and Germany. A detailed phylogenetic analysis showed low intra-cluster sequence variability, but high inter-cluster divergence suggesting a long-term SWSV evolution in local shrew populations. In conclusion, the investigations demonstrated a broad geographical distribution and multiple spillover infections of rodent-borne TULV and shrew-borne SWSV in Europe. The finding of putative spillover transmissions described here and in other studies underline the current problem of the hantavirus reservoir host definition. In contrast to the hypothesis of a long-standing hantavirus–rodent (small mammal) host coevolution, the investigations support a more dynamic evolutionary history of hantavirus diversification including spillover infections and host-switch events. In future in vitro and in vivo infection studies as well as field studies has to define factors determining the host specificity of these hantaviruses.
A molecular approach to characterize the arbuscular mycorrhizal fungus, Glomus sp. AMykor isolate
(2012)
The arbuscular mycorrhizal fungi (AMF) interaction with plants has a major impact on the soil ecosystem. However, so far, only a few studies on AMF genetics have been performed and molecular information on the genetic diversity of AMF is limited. In this study a fundamental genetic characterization of the industrial isolate, Glomus sp. AMykor (AMykor GmbH, Bitterfeld, Germany) has been undertaken to increase the understanding of AMF genetic diversity. Based on phylogenetic analysis of partial rDNA sequences, Glomus sp. AMykor isolate was proposed to belong to the G. irregulare species together with the reference isolate, DAOM197198. To investigate if both isolates differ in their ploidy level, fluorescence in situ hybridization (FISH) was performed and mainly one or two hybridization signals per nucleus were observed in both isolates. It is suggested that they harbour at least two major rDNA sites and possibly two minor sites. The DNA content was estimated by means of flow cytometry (FC) and confirmed by Feulgen densitometry (FD). The calculated average DNA content per nucleus is 153.0 ± 3.6 Mb for the G. irregulare AMykor isolate and 154.8 ± 6.2 Mb for the DAOM197198 isolate. Since there are plenty criticisms coming recently of using rDNA sequence for fungal barcoding there is necessity of development other system for the identification to species level of Glomeromycotan fungi. The focus of this part of the study was the GiFRD gene encoding fumarate reductase enzyme for use as a potential candidate for AMP species determination. Unfortunately, observed sequence variations do not allow the discrimination of Glomeromycotan species. However, further analysis of enzyme encoded by GiFRD showed a possible role of fumarate reductase in AMF redox balance maintaining under oxygen deficient conditions. Using a yeast expression system, it has been demonstrated that the protein encoded by GiFRD has fumarate reductase activity. The functional expression of GiFRD in the S. cerevisiae fumarate reductase deletion mutant restored the ability of growth under anaerobiosis which indicated that Gifrdp is able to functionally complement the S. cerevisiae missing genes. The fact that GiFRD expression was present only in the asymbiotic stage confirmed existence of at least one metabolic pathway involved in anaerobic metabolism and suggested that AMF behave as a facultative anaerobe in asymbiotic stage.
The leading hypothesis of why organisms age is the “Free Radical Theory of Aging”, which states that the accumulation of reactive oxygen species (ROS), such as superoxide (O2•-) and hydrogen peroxide (H2O2), causes protein, lipid and DNA damage and leads to the observed age-related decline of cells and tissues. A major obstacle in analyzing the role of oxidative stress in aging organisms is the inability to precisely localize and quantify the oxidants, to identify proteins and pathways that might be affected, and ultimately, to correlate changes in oxidant levels with the lifespan of the organism. To directly monitor the onset and extent of oxidative stress during the lifespan of Caenorhabditis elegans, we utilized the fluorescent H2O2 sensor protein HyPer, which enabled us to quantify endogenous peroxide levels in different tissues of living animals in real time. We made the surprising observation that wildtype C. elegans is exposed to very high peroxide levels during development. Peroxide levels drop rapidly as the animals mature, and low peroxide levels then prevail throughout the reproductive age, after which an age-accompanying increase of peroxide level is observed. These results were in excellent agreement with findings obtained by using the highly quantitative redox proteomic technique OxICAT, which monitors the oxidation status of redox-sensitive proteins as read-out for onset, localization, and protein targets of oxidative stress. By using OxICAT, we detected increased protein thiol oxidation during the development of C. elegans and in aging animals. Many processes in C. elegans might potentially contribute to the elevated peroxide levels observed during development, including cuticle formation, apoptosis, proliferation, gametogenesis, or ROS signaling. The finding that all investigated C. elegans mutants regardless of their lifespan are exposed to high developmental peroxide levels argues for ROS accumulation to be a universal and necessary event. Yet, recovery from the early oxidative boost might determine the subsequent adult lifespan, as we found that long-lived daf-2 mutants transition faster to reducing conditions than short-lived daf-16 mutants, which retain higher peroxide levels throughout their mature life. These results suggest that changes in the cellular oxidant homeostasis, encountered at a very early stage in life, might determine subsequent redox levels and potentially the lifespan of organisms. Manipulation of developmental oxidant levels using glucose restriction or a short bolus of superoxide caused a disruption in developmental growth, a delay in reproduction, and a shortened lifespan. These results suggest that developmental oxidant levels are fine-tuned and optimized. Future experiments are aimed to investigate the sources of developmental hydrogen peroxide, and to elucidate whether active down-regulation of antioxidant enzymes during the larval period might foster peroxide accumulation. Preliminary results indicate that this might indeed be the case for peroxiredoxin 2, whose expression was significantly lower during development than at later stages in life. Finally, we investigated whether the observed variances in the developmental peroxide levels of individual worms within a synchronized wildtype population might be responsible for the observed significant variances in lifespan, and hence could serve as a predictor for adult lifespan. Preliminary results revealed that neither too low nor too high peroxide levels during development are beneficial for the lifespan of wildtype worms, suggesting that ROS level during development might be optimized for maximized lifespan. Future experiments aim to reveal the processes that are affected by ROS and which might influence the individual’s lifespan early in life.
Streptococcus pneumoniae (pneumococci) are Gram-positive cocci and commensals of the human upper respiratory tract. Pneumococcal pathogenesis requires adherence to host cells and dissemination through cellular barriers and to evade host defense mechanisms. The Pneumococcal surface protein C (PspC) is an important virulence factor which has a crucial role in pneumococcal adhesion to host cells and immune evasion by manipulating the host complement system. To elucidate the pneumococcal adherence and uptake mechanism via factor H glycosaminoglycans (dermatan sulfate and heparin) were employed as competitive inhibitors in infection experiments with epithelial cells or human polymorphonuclear leukocytes (PMNs). Glycosaminoglycans significantly inhibited the FH mediated pneumococcal adherence and subsequent invasion to host epithelial cells. Furthermore, the short consensus repeats of FH which promotes the adhesion of pneumococci to host cells were identified by blocking experiments with domain mapped antibodies for specific regions of FH. Moreover, this study indicates that FH acts as adhesion molecule via cellular receptors recognized as integrin CR3 on human PMNs. Binding of Factor H loaded pneumococci to integrins CR3 was assessed by flow cytometry. Pneumococci coated with Factor H showed a significantly increased association with PMNs. This interaction was blocked by anti-CR3 antibodies and Pra1. This project further aims to study mechanisms of pneumococcal endocytosis by host cells, their intracellular fate, and the pathogen induced host cell signal transduction cascades including the calcium signaling upon pneumococcal infection of host cells via the PspC-hpIgR interaction. To assess now the role of protein tyrosine kinases (PTKs) during pneumococcal infection via PspC, cell culture infections were performed in presence of pharmacological inhibitors of PTKs and MAPKs or by employing genetic interference techniques. Blocking the function of Src or ER1/2 and JNK and genetic-knock down of Src and FAK reduced significantly internalization of pneumococci. These data indicated the importance of a coordinated signaling between Src PTKs, ERK1/2, and JNK during PspC-pIgR-mediated uptake of pneumococci by host epithelial cells. The impact of host cells intracellular calcium concentrations on pneumococcal PspC-hpIgR mediated internalization was studied. Intracellular calcium measurement of epithelial cells performed in the presence of pneumococci suggested a calcium influx in host epithelial cells and importantly this calcium influx was PspC- hpIgR specific as pspC-deficient pneumococci were unable to mediate calcium mobilization in host cells. The increase in intracellular calcium [Ca2+]i was dependent on phospholipase C as pretreatment of cells with a phospholipase C-specific inhibitor abolished the increase in [Ca2+]i. Furthermore, role of host intracellular calcium concentrations during pneumococcal internalization was demonstrated by employing specific pharmacological inhibitors and calcium chelators in epithelial cell culture infection assays. The results revealed that elevated host cells calcium concentrations diminished pneumococcal internalization while lower calcium concentration in host epithelial cells promoted pneumococcal uptake. This study further demonstrates that dynamin, clathrin and caveolin play a key role during pneumococcal endocytosis into host cells via PspC-hpIgR. The use of specific pharmacological inhibitors or genetic interference approaches against dynamin, clathrin and caveolin in epithelial cell culture infection assays significantly blocked pneumococcal uptake. Furthermore, confocal microscopy revealed that pneumococci co-localize with clathrin. At later stages of the infection the pathogen is sorted to early, late and recycling endosomes as indicated by co-localization of pneumococci with endosomal markers such as Rab5, Rab4, Rab 7, and Lamp1. In order to get further insights into PspC-hpIgR mediated uptake mechanisms, a chimeric PspC was constructed and expressed heterologously on the surface of Lactococcus lactis. Immunofluorescence staining, immunoblot and flow cytometric analysis of L. lactis confirmed the expression of PspC on the bacterial surface. Moreover the ability of recombinant lactococci expressing PspC to adhere to and to invade pIgR-expressing epithelial cells confirmed the functional activity of PspC when exposed on the lactococcal surface. PspC expressing lactococci confirmed the specificity of PspC-hpIgR mediated endocytosis in host epithelial cells as PspC deficient lactococci were not taken up by these host cells. Confocal microscopic analysis demonstrated that only PspC expressing lactococci were sorted to early, late and recycling endosomes, similar to the intracellular fate of S. pneumoniae.
Streptococcus pneumoniae, more commonly known as the pneumococcus, is a Gram-positive bacterium colonizing the human upper respiratory tract as a commensal. However, these apparently harmless bacteria have also a high virulence potential and are known as the etiologic agent of respiratory and life-threatening invasive diseases. Dissemination of pneumococci from the nasopharynx into the lungs or bloodstream leads to community-acquired pneumonia, septicaemia and meningitis. Pneumococcal diseases are treated with antibiotics and prevented with polysaccharide-based vaccines. However, due to the increase of antibiotic resistance and limitations of the current vaccines, the burden of diseases remains high. Interactions of pneumococci with soluble host proteins or cellular receptors are crucial for adherence, colonization, transmigration of host barriers and immune evasion. The pneumococcal surface-exposed proteins are the main players involved in this host-pathogen interaction. Therefore, combating pneumococcal transmission and infections has emphasized the need for a new generation of immunogenic and highly protective pneumococcal vaccines, based on surface-exposed adhesins virtually expressed by all pneumococcal strains and serotypes. The genomic analysis of S. pneumoniae strains helped to identify pneumococcal virulence factors such as pili, PsrP and PavB, which have been demonstrated to interact with human proteins playing an important role during the pathogenic process of pneumococci, and are currently considered as new potential vaccine candidates against S. pneumoniae. A subclass of pneumococcal strains produces pili that are encoded by the pathogenicity islet pilus islet-1 (rlrA islet) and/or the pilus islet-2. Both types of pili are implicated in bacterial adherence to host cells. A further pathogenicity islet encoded protein is PsrP. The presence of the psrP-secY2A2 islet correlated positively with the ability of pneumococci to cause invasive pneumococcal diseases. Recent studies indicated that PsrP is a protective adhesin interacting with keratin 10 on lung epithelial cells. In this study, the genomic loci of the pneumococcal virulence factors pili, PsrP and PavB were molecularly analyzed and used as molecular markers for molecular epidemiology studies of S. pneumoniae. The genotyping results obtained here showed the impact of the PCV7 immunization of children, started in July 2006, on the distribution of these pneumococcal virulence factors among clinical isolates in Germany. These findings gave more insights into the role of pili, PsrP and PavB in pneumococcal pathogenesis and may strongly support the idea of including these pneumococcal constituents in a broad coverage protein-based vaccine against pneumococcal infections produced by invasive serotypes in the future. The mature PavB protein contains a variable number of repetitive sequences referred to as the Streptococcal Surface Repeats (SSURE). PavB has been demonstrated to interact with fibronectin and plasminogen in a dose-dependent manner and it was identified as a surface-exposed adhesin with immunogenic properties, which contributes to pneumococcal colonization and respiratory airways infections. The complete molecular analysis performed here for PavB, allowed to know more accurately its structure and to estimate the real number of SSURE units in different pneumococcal strains. With these findings, a new primary sequence-based structural model was constructed for the PavB protein and its SSURE domain, and, at least for TIGR4, the complete pavB gene and PavB protein sequences with five SSURE units was reported in the GenBank database of the NCBI website. Due to its immediate neighborhood on the pneumococcal genome with the tcs08 genes, PavB is likely linked with this pneumococcal TCS. Here, a significant reduction of the PavB protein expression was observed in delta-tcs08-mutant strains, which may strongly suggest that the TCS08 does play a role in pneumococcal virulence and metabolisme, as further observed in growth behaviour experiments carried out with the TCS08-deficient mutants, cultured in chemically defined medium. Despite several studies suggest that the molecular mechanism underlying the bacterial signal transduction is very sophisticated, the majority of reports in prokaryotic TCS, including those for S. pneumoniae, are still focused in single cognate pairs. The pneumococcal genome encodes 14 TCSs and an orphan response regulator. It is obvious that TCS pathways are often arranged into complex circuits with extensive cross-regulation at a variety of levels, thereby endowing cells with the ability to perform sophisticated information processing tasks. This study established also the experimental and molecular bases for the construction of a comprehensive genome-wide interaction map of the complex TCS pathways for its application in the gene regulation of pneumococcal virulence factors.
Hyperuricemia and its symptoms are becoming increasingly common worldwide. Elevated serum uric acid levels are caused by increased uric acid synthesis from food constituents and reduced renal excretion. Treatment in most cases involves reducing alcohol intake and consumption of meat and fish or treatment with pharmaceuticals. Another approach could be to reduce uric acid level in food, either during production or consumption. This work reports the production of recombinant urate oxidase by Arxula adeninivorans and its application to reduce uric acid in a food product. The A. adeninivorans urate oxidase amino acid sequence was found to be similar to urate oxidases from other fungi (61-65% identity). In media supplemented with adenine, hypoxanthine or uric acid, induction of the urate oxidase (AUOX) gene and intracellular accumulation of urate oxidase (Auoxp) was observed. The enzyme characteristics were analyzed from isolates of the wild-type strain A. adeninivorans LS3, as well as from those of transgenic strains expressing the AUOX gene under control of the strong constitutive TEF1 promoter or the inducible AYNI1 promoter. The enzyme showed high substrate specificity for uric acid, a broad temperature and pH range, high thermostability and the ability to reduce uric acid content in food.
Gout was described by Hippocrates in the 5th century BC as a disease of rich people and linked with excess food and alcohol. It is caused by long-lasting hyperuricemia, which is a result of an imbalance between excretion and production of uric acid. The surplus of uric acid leads to deposition of monosodium urate crystals in the joints, which can initiate a painful inflammation called a gout attack. Despite various pharmacological treatments for this disease, a low purine diet remains the basis of all gout therapies. Since food is rich in purines, the aim of this project was to develop a novel enzyme system to decrease the purine content of food, what should result in reduced serum urate concentration in patients with hyperuricemia. The system consists of five degrading enzymes (adenine deaminase, guanine deaminase, xanthine oxidoreductase, urate oxidase and purine nucleoside phosphorylase) that combined in one product are able to hydrolyse all purines to a highly soluble allantoin, which can be easily removed from the body. This approach provides the patients a possibility to reduce the symptoms and frequency of gout attacks or even doses of prescribed drugs. In order to obtain necessary system components, yeast Arxula adeninivorans LS3 was screened for enzyme activities. A. adeninivorans is known to utilise various purines and this ability is a result of activity of desired enzymes, two of which, adenine deaminase and xanthine oxidoreductase, are in focus of this thesis. The analysis of growth of A. adeninivorans on various carbon and nitrogen sources gave the first insight into the cells’ nutrient preferences indicating the presence of purine degrading enzymes, such as adenine deaminase and xanthine oxidoreductase. Purines, such as adenine and hypoxanthine, could be utilised by this yeast as sole carbon and nitrogen sources and were shown to trigger the gene expression of the purine degradation pathway. Enzyme activity tests and quantitative real-time PCR method allowed for identification of the best inducers for adenine deaminase and xanthine oxidoreductase, as well as their concentration and time of induction. The adenine deaminase (AADA) and the xanthine oxidoreductase (AXOR) genes were isolated and subjected to homologous expression in A. adeninivorans cells using Xplor®2 transformation/expression platform. The selected transgenic strains accumulated the recombinant adenine deaminase in very high concentrations. The expression of AXOR gene posed difficulties and remained a challenge. Additional expression of both proteins in alternative E. coli system was undertaken but failed for AXOR gene. The recombinant adenine deaminase and wild-type xanthine oxidoreductase were purified and characterized biochemically. The characterization included determination of optimal pH and temperature, stability in different buffers and temperatures, molecular weight, substrate spectrum, enzyme activators and inhibitors, kinetics and intracellular localisation. The determination of these parameters was necessary to ensure optimal conditions for application of these enzymes in the industry. At the final stage, the enzymes were combined in one mix with provided guanine deaminase and urate oxidase and used to degrade purines in selected food constituents. The application was successful and demonstrated the potential of this approach for the production of food with lower purine concentration.
Background: Hepatitis E virus (HEV) is the etiological agent of an acute self-limiting hepatitis in humans worldwide. The main route of infection is by ingestion of food or water contaminated with the virus. In Germany, several hundred human cases are reported each year, while preliminary studies suggest a high infestation rate of herds of domestic pig (Sus scrofa domesticus) and sounders of wild boar (Sus scrofa). Autochthonous cases are originating mainly from zoonotic transmission from domestic pig and wild boar, but other animals may also be involved. Recently, a novel strain of HEV (ratHEV) had been found in Norway rats (Rattus norvegicus) in Germany, that could contribute to human epidemiology. Therefore, the aim of this study was to assess the seroprevalence of both HEV and the novel ratHEV in human, domestic pig and rat. For each of the three mammal species, an indirect immunoglobulin G (IgG) enzyme-linked immunosorbent assay (ELISA) was established, that based on an Escherichia coli-expressed carboxy-terminal segment (GT3-Ctr, amino acid (aa) 326–608) of the capsid protein of the autochthonous genotype 3 (GT3), derived from a wild boar from Germany. In parallel, a segment from ratHEV homologous to GT3-Ctr was also expressed in E. coli (ratHEV-Ctr, aa315–599) and was used in the ELISA. Hence, the established tests detect antibodies directed against HEV GT3 when using GT3-Ctr as antigen and ratHEV when using ratHEV-Ctr. Results: The GT3-based in-house human IgG test was validated using a commercial assay and showed high specificity and sensitivity. The average human population (represented by a panel of blood donors from Berlin and Brandenburg) reached a seroprevalence of 12.3% (37/301) with the in-house ELISA. A panel of forestry workers from Brandenburg had an even higher seroprevalence of 21.4% (119/555). Furthermore, ratHEV-specific antibodies could be detected in several sera of forestry workers. The novel ratHEV-based rat IgG ELISA could not be compared to similar tests, however, parallel testing with GT3-Ctr and statistical inference allowed conclusion of a seroprevalence. Rats trapped from several sites in Germany had an overall seroprevalence of 24.5% (36/147). The sera were reactive exclusively with ratHEV-Ctr. As with the in-house ELISA for human sera, the porcine IgG test was validated using a commercial assay, yielding high specificity and sensitivity. A panel of domestic pigs from ten federal states of Germany showed a seroprevalence of 42.7% (383/898) when tested with the in-house ELISA. Reactivity with ratHEV was present, but seemed to be caused mostly by cross-reactivity to GT3-Ctr. Conclusion: The HEV seroprevalence observed for human sera of the average population of Germany is among the highest in Europe and has been confirmed recently by other authors. The high seroprevalence found in forestry workers suggests that they should be counted as a risk group for HEV infection. Populations of rats have been shown to be infested heavily with ratHEV, as rats from all trapping sites situated within cities had a high prevalence for ratHEV exclusively and no serum reacted exclusively with GT3-Ctr. Seroprevalence in domestic pigs was demonstrated to be distributed evenly across federal states and districts. However, a vast difference of infestation could be detected in different herds, suggesting either differences in husbandry conditions, or an external source of infection that acts locally only. The rare but exclusive reactivity of human sera with ratHEV as well as the high cross-reactivity of swine sera with ratHEV suggests that viral strains other than the ones already known may contribute to cases of hepatitis E.
Purines of exogenous and endogenous sources are degraded to uric acid in human beings. Concentrations >6.8 mg uric acid/dl serum cause hyperuricemia and its symptoms. Pharmaceuticals and the reduction of the intake of purine-rich food are used to control uric acid levels. A novel approach to the latter proposition is the enzymatic reduction of the purine content of food by purine-degrading enzymes. Here we describe the production of recombinant guanine deaminase by the yeast Arxula adeninivorans LS3 and its application in food. In media supplemented with nitrogen sources hypoxanthine or adenine, guanine deaminase (AGDA) gene expression is induced and intracellular accumulation of guanine deaminase (Agdap) protein occurs. The characteristics of the guanine deaminase isolated from wild-type strain LS3 and a transgenic strain expressing the AGDA gene under control of the strong constitutive TEF1 promoter were determined and compared. Both enzymes were dimeric and had temperature optima of 55°C with high substrate specificity for guanine and localisation in both the cytoplasm and vacuole of yeast. The enzyme was demonstrated to reduce levels of guanine in food. A mixture of guanine deaminase and other purine degradation enzymes will allow the reduction of purines in purine-rich foods.
Transcriptional repression of regulated structural genes in eukaryotes often depends on pleiotropic corepressor complexes. A well-known corepressor conserved from yeast to mammalian systems is Sin3. In addition to Sin3, yeast Cyc8/Tup1 corepressor complex also regulates a diverse set of genes. Both corepressors can be recruited to target genes via interaction with specific DNA-binding proteins, leading to down-regulation of a large number of unrelated structural genes by associated histone deacetylases (HDACs). In vitro interaction studies performed in this work by GST pull-down assays showed that various repressor proteins (such as Whi5, Stb1, Gal80, Rfx1, Ure2, Rdr1, Xbp1, Yhp1, Rox1, Yox1, Dal80 and Mot3) are indeed able to bind pleiotropic corepressors Sin3 and/or Cyc8/Tup1. All repressors interacting with Sin3 contact its paired amphipathic helix domains PAH1 and/or PAH2. Mapping experiments allowed the characterization of minimum repressor domains and to derive a sequence pattern which may be important for repressor interaction with Cyc8 or Sin3. Interactions for some pathway-specific repressors such as Cti6 and Fkh1 have been studied comprehensively; minimal domains of Cti6 and Fkh1 required for interaction with Sin3 have been mapped and subsequently investigated by mutational analysis. In vitro interaction studies could show that amino acids 350-506 of Cti6 bind PAH2 of Sin3. To analyze this Cti6-Sin3 interaction domain (CSID) in more detail, selected amino acids within CSID were replaced by alanine. It turned out that hydrophobic amino acids V467, L481 and L491 L492 L493 are important for Cti6-Sin3 binding. The results of this work also suggest that repression is not executed entirely via Sin3, but rather CSID is also important for contacting pleiotropic corepressor Cyc8. In addition to PAH2 of Sin3, CSID also binds to tetratricopeptide repeats (TPR) of Cyc8. Furthermore, in vitro mapping studies revealed that Fkh1 also binds PAH2 of corepressor Sin3 via its N-terminal domain (aa 51-125). Binding studies with mutagenized Fkh1-Sin3 interaction domain (FSID) showed that Fkh151-125 variants L74A and I78A were unable to bind PAH2 of Sin3. Confirming in vitro studies, Cti6350-506 and Fkh151-125 also displayed in vivo interaction with PAH2 of Sin3 by using the “yeast two -hybrid” system. Chromatin immunoprecipitation (ChIP) analyses have demonstrated Cti6 recruitment to promoters of genes such as RNR3 and SMF3 containing iron responsive elements (IRE). Importantly, Sin3 was also recruited to these promoters but only in the presence of functional Cti6. Similarly, recruitment of Fkh1 and Sin3 to promoters of cell-cycle regulated genes CLB2 and SWI5 was shown. Recruitment of Sin3 was completely Fkh1-dependent. Additional findings of this work shed light on the fact that not only repressor proteins may contact Sin3 but also activator proteins not yet considered for interaction, e. g. specific activators such as Pho4 and Ino2. These findings indicate that Sin3 may fulfill functions beyond acting as a corepressor. In vitro studies on Sin3-Pho4 interaction showed that aa 156-208 of Pho4 are able to bind both PAH1 and PAH2 of Sin3, while an internal region of Ino2 comprising amino acids 119-212 binds to both Sin3 and Cyc8.
Streptococcus pneumoniae (the pneumococcus) is a harmless resident of the human nasopharyngeal cavity, and, in general, every individual is likely to be colonized asymptomatically at least once during life. However, under certain conditions, the bacterium can spread to other tissues and organs causing local, non-invasive infections but also lifethreatening, invasive diseases. Pneumococcal carriage and infection is a highly regulated interplay between pathogen- and host-specific factors and the intimate contact of S. pneumoniae with the surface of the nasopharynx is the crucial step in pneumococcal pathogenesis. Pneumococcal adherence to the respiratory epithelium is mediated by surface-exposed adhesins. These adhesins engage host cell receptors either directly or indirectly by recognizing glycoproteins of the extracellular matrix (ECM) including structural components, such as collagens, laminins, and fibronectins, as well as plasma-derived ECM modulators, like vitronectin and Factor H. Pneumococcal surface protein C (PspC) is a surface-exposed protein and important virulence factor of S. pneumoniae. The multifunctional PspC protein promotes pneumococcal adherence to host cells by interacting with the secretory component of the human polymeric Immunoglobulin receptor of respiratory cells. In addition, PspC facilitates pneumococcal immune evasion by recruiting the complement inhibitor proteins C4b-binding protein (C4BP) and Factor H. Moreover, Factor H bound to the pneumococcal surface promotes bacterial adhesion to human epithelial and endothelial cells. S. pneumoniae also interacts with the human glycoprotein vitronectin. In plasma, monomeric vitronectin regulates thrombosis, fibrinolysis and the terminal complement cascade, while it additionally mediates cell-matrix interactions, cell adhesion and migration in the ECM. It was shown that multimeric, ECM-associated vitronectin facilitates pneumococcal adherence to respiratory epithelial cells. In addition, the interaction of pneumococci with vitronectin promotes their uptake by mucosal epithelial cells via the engagement of the integrin αvβ3 receptor and activation of intracellular signaling pathways culminating in cytoskeletal rearrangements. This study aims to identify and characterize the surface-exposed protein(s) that mediate binding of pneumococci to vitronectin and to elucidate the impact of vitronectin on pneumococcal pathogenesis beyond its function as molecular bridge between pneumococcus and host. Flow cytometric, immunosorbent and surface plasmon resonance experiments revealed that PspC is a vitronectin-binding protein of S. pneumoniae. The specificity of the interaction with vitronectin was confirmed using recombinant PspC proteins and Lactococcus lactis heterologously expressing PspC on their surface. Factor H did not hinder vitronectinbinding to PspC indicating that vitronectin recognizes the central part of PspC. Secretory IgA inhibited but not completely prevented vitronectin-binding to PspC, strongly suggesting that vitronectin binds near, but not directly to, the SC-binding region within the R domain(s) of PspC. In addition, PspC proteins comprising two R domains bound with higher affinity to vitronectin than PspC containing only one R domain, indicating that two interconnected R domains are required for efficient vitronectin-binding. Despite the sequential and structural differences to classical PspC, the PspC-like protein Hic specifically interacted with vitronectin with similar affinity than PspC containing two linked R domains. Binding studies confirmed that Factor H interacts with the very N-terminal region of Hic showing high sequence homology to classical PspC proteins, while vitronectin recognizes an adjacent region in the N-terminal region of Hic. The studied PspC proteins bound to both soluble and immobilized vitronectin, and the C-terminal heparin-binding domain (HBD3) was identified as PspC-binding motif in soluble vitronectin. However, in its immobilized form, vitronectin likely exposes additional binding sites for PspC since a region N-terminally to the identified HBD3 conferred binding of PspC. Vitronectin inhibits the terminal complement pathway, thereby preventing proinflammatory immune reactions and tissue damage. In general, pneumococci are protected from opsonization and MAC-dependent lysis by their capsule. However, pneumococci in close contact to human cells can become susceptible to complement attack due to reduced amounts of capsule. In addition, they can be severely affected by TCC-induced inflammatory responses. Vitronectin bound to PspC significantly inhibited the formation of terminal complement complexes. Thus, the interaction of PspC with vitronectin might aid in immune evasion of S. pneumoniae by inhibiting complement-mediated lysis and/or suppressing proinflammatory events. In conclusion, the results revealed the multifunctional PspC and Hic as vitronectin-binding proteins and proposed a novel role for the specific interaction of S. pneumoniae with vitronectin in regulating the complement cascade, beside its function as molecular bridge to the respiratory epithelium.
Invasion of the bacterial pathogen Listeria monocytogenes into human host cells requires specialized surface molecules for attachment and induction of phagocytosis. However, efficient invasion is also dependent on factors with house-keeping functions, such as SecA2-dependent secretion of autolysins for post-divisional segregation of daughter cells. Mutations in this pathway prevent degradation of peptidoglycan cross-walls, so that long cell chains are formed that cannot be phagocytosed. The extreme chaining of such mutants manifests as rough colony phenotype. One rough clone was isolated from a transposon library with a transposon insertion in the uncharacterized lmo0720 gene (lftS) together with a spontaneous point mutation in the secA2 gene. We separated both mutations and demonstrated that this point mutation in the intramolecular regulator 2 domain of SecA2 was sufficient to inactivate the protein. In contrast, lftS deletion did not cause a ΔsecA2-like phenotype. lftS is located in an operon with lftR (lmo0719), encoding a PadR-like transcriptional regulator, and lftR deletion affected growth, invasion and day-light dependent coordination of swarming. Inactivation of lftS partially suppressed these phenotypes, suggesting a functional relationship between LftR and LftS. However, the invasion defect of the ΔlftR mutant was only marginally suppressed by lftS removal. LftR regulates expression of the lmo0979–0980 (lieAB) operon, encoding a putative multidrug resistance transporter and lieAB transcription was strongly upregulated in the absence of LftR. Deletion of lieAB in the ΔlftR background restores wild type-like invasion levels. Hence, we conclude that tight transcriptional repression of the lieAB operon is essential for efficient listerial host cell invasion.
Streptococcus pneumoniae (pneumococci) are lancet-shaped, Gram-positive, alpha-hemolytic, facultative anaerobic human specific commensals of the upper and lower respiratory tract. Pneumococci may convert to pathogenic bacteria and spread to the lungs and blood. In different population groups, such as children, the elderly and immunocompromised individuals, pneumococci can cause local infections such as bronchitis, rhinitis, acute sinusitis, and otitis media as well as life-threatening invasive diseases such as community-acquired pneumonia, sepsis and meningitis. Pneumococci are surrounded by a rigid and complex exoskeleton, the peptidoglycan, also referred to as murein sacculus. The peptidoglycan (PNG) protects the cells from rupture by osmotic pressure and maintains their characteristic shape. The PNG is a heteropolymer made up of glycan strands that are cross-linked by short peptides and during growth the existing murein is continuously hydrolyzed by specific lytic enzymes to enable the insertion of new peptidoglycan. Bacterial cell-wall hydrolases are essential for peptidoglycan turnover and crucial to preserve cell shape. The D,D-carboxypeptidase DacA and L,D-carboxypeptidase DacB of Streptococcus pneumoniae function in a sequential manner. This study determined the crystal structure of the surface-exposed lipoprotein DacB, which differs considerably from the DacA structure. DacB contains a Zn2+ ion in its catalytic center located in the middle of a fully exposed, large groove. Two different conformations with differently arranged active site topology were identified. In addition the critical residues for catalysis and substrate specificity were identified. Deficiency in DacA or DacB resulted in a modified peptidoglycan peptide composition and led to an altered cell shape of the dac-mutants. In contrast, lgt-mutant lacking lipoprotein diacylglyceryl transferase activity required for proper lipoprotein maturation retained L,D-carboxypeptidase activity and showed an intact murein sacculus. Furthermore, this study demonstrated the pathophysiological effects of disordered DacA or DacB activities. Real-time bioimaging of intranasally infected mice indicated a substantially attenuated virulence of dacB- and dacAdacB-mutants pneumococci, while loss of function of DacA had no significant effect. In addition, uptake of these mutants by professional phagocytes was enhanced, while their adherence to lung epithelial cells was decreased. The second part of this study focused on the functional and structure determination of the soluble dimeric pneumococcal lipoprotein PccL. Because of its calycin fold and structural homology with the lipocalin YxeF from Bacillus subtilis, PccL was introduced as the first member of the lipocalin protein family in pneumococci and named “PccL” (Pneumococcal calycin fold containing Lipoprotein). Similar to other lipocalins, the distinct beta-barrel, which is open at one end, is significantly conserved in PccL. Moreover, the application of the in vivo acute pneumonia mouse infection model and the in vitro phagocytosis as well as adherence invasion studies revealed considerable differences in colonization and invasive infection between the wild-type D39 and the pccL-mutant. In conclusion, this study characterized the crucial role of pneumococcal carboxypeptidases DacA and DacB for PGN architecture, bacterial shape and pathogenesis. By applying in vivo and in vitro approaches, a close relationship between PGN metabolism and pathophysiological effects was discovered. In addition, the high resolution structure of DacB has been solved and analyzed and a structure model with a resolution of 2.0 Å is provided. Furthermore, analysis of the PGN composition was applied to indicate the impact of an impaired lipoprotein biogenesis pathway on localization and activity of DacB. The major impact of carboxypeptidases on cell shape and virulence proposes DacB as a promising target for the development of novel drugs or due to its surface exposition also as a promising vaccine candidate. PccL is the first pneumococcal lipocalin-like protein and this study indicated its contribution to pneumococcal virulence. However, the mechanism and the mode of action of PccL are still unknown and have to be deciphered in further studies.
Certain pathogenic bacteria adopt an intracellular lifestyle and proliferate in eukaryotic host cells. The intracellular niche protects the bacteria from cellular and humoral components of the mammalian immune system, and at the same time, allows the bacteria to gain access to otherwise restricted nutrient sources. Yet, intracellular protection and access to nutrients comes with a price, i.e., the bacteria need to overcome cell-autonomous defense mechanisms, such as the bactericidal endocytic pathway. While a few bacteria rupture the early phagosome and escape into the host cytoplasm, most intracellular pathogens form a distinct, degradation-resistant and replication-permissive membranous compartment. Intracellular bacteria that form unique pathogen vacuoles include Legionella, Mycobacterium, Chlamydia, Simkania, and Salmonella species. In order to understand the formation of these pathogen niches on a global scale and in a comprehensive and quantitative manner, an inventory of compartment-associated host factors is required. To this end, the intact pathogen compartments need to be isolated, purified and biochemically characterized. Here, we review recent progress on the isolation and purification of pathogen-modified vacuoles and membranes, as well as their proteomic characterization by mass spectrometry and different validation approaches. These studies provide the basis for further investigations on the specific mechanisms of pathogen-driven compartment formation.
The influence of regulatory proteins on the physiology and virulence of Streptococcus pneumoniae
(2015)
In conclusion, this work identifies the regulator ArgR2 as activator of the S. pneumoniae TIGR4 arginine deiminase system and arginine-ornithine transporter ArcD, which is needed for uptake of the essential amino acid arginine. Although ArgR2 activates ArcD expression and uptake of arginine is required to maintain pneumococcal fitness, the deficiency of ArgR2 increases TIGR4 virulence under in vivo conditions, suggesting that other factors regulated by ArgR2 counterbalance the reduced uptake of arginine by ArcD. Thus this works illustrates that the physiological homeostasis of pneumococci is complex and that ArgR2 plays a key role in maintaining bacterial fitness. Moreover, Rex was identified as a regulator of housekeeping genes including genes encoding glycolytic enzymes. In vitro studies and gene expression analyses suggested that the regulator Rex does not have an influence on the physiology of S. pneumoniae. However, a co-infection experiment demonstrated that Rex is involved in maintaining pneumococcal fitness and robustness under in vivo conditions.
Alcohol dehydrogenases as biocatalysts for the production of enantiomerically pure chiral alcohols
(2016)
Summary Enantiomerically pure chiral alcohols are key compounds in the production of certain chemicals including pharmaceuticals. Chemical synthesis allows to obtain maximal yield of 50% for one enantiomer ( >50% yield is achievable with chiral catalysts used in chemical synthesis), whereas biosynthesis leads to nearly 100% yield. Hence, expensive and time consuming resolution of racemic mixture can be avoided. Alcohol dehydrogenases are the most popular enzymes used in the chiral alcohols synthesis due to high activity with appropriate aldehydes or ketones. ADHs require a cofactor which has to be regenerated after the conversion of aldehyde/ketone to the respective alcohol. Thereby, different regeneration methods were used in the practical work to compare and choose the better one. R. erythropolis and C. hydrogenoformans alcohol dehydrogenases were chosen based on the literature screening. Each gene was cloned into Xplor2 vector and pFPMT vector. Xplor2 vector was used for the transformation of A. adeninivorans and pFPMT vector was used for the transformation of H. polymorpha. Chemically synthesized alcohol dehydrogenase sequences from R. erythropolis (ReADH) and C. hydrogenoformans (ChADH) were cloned between TEF1 promoter and PHO5 terminator which are components of Xplor2 vector or between FMD promoter and MOX terminator which are genetic elements of pFPMT vector. Moreover, ChADH and ReADH sequences with His-tag encoding sequence at the 5’ or 3’ end were constructed and the most active form of the protein was selected for further studies. ReADH-6H was used for the synthesis of 1-(S)-phenylethanol and ethyl (R)-4-chloro-3-hydroxybutanoate whereas ChADH-6H was used for the production of ethyl (R)-mandelate. ReADH-6H synthesized in A. adeninivorans and H. polymorpha was fully biochemically characterized. The enzymes from the two yeast species showed some differences in their pH and temperature optima, thermostability and activity levels. A-ReADH (A. adeninivorans) and H-ReADH (H. polymorpha) were highly active with the same substrates which were: acetophenone, 4-hydroxy-3-butanone and ethyl 4-chloroacetoacetate for reduction reaction along with 1-phenylethanol and 1,6-hexanediol for oxidation reaction. Recombinant A-ReADH-6H and H-ReADH-6H were synthesized in A. adeninivorans and H. polymorpha, respectively. Both enzymes were used for the synthesis of 1-(S)-phenylethanol and ethyl (R)-4-chloro-3-hydroxybutanoate with the use of substrate-coupled cofactor regeneration system. The enantiopurity of the products was >99%. Moreover, A. adeninivorans whole cell catalyst was also used for the synthesis of both chiral alcohols. BmGDH (Bacillus megaterium glucose dehydrogenase) was co-expressed with ReADH-6H for NADH cofactor regeneration. Comparison between isolated enzymes and permeabilized whole cell catalysts indicate that cell biocatalysts are more suitable for the production of 1-(S)-phenylethanol with 92% of acetophenone being converted in 60 min. However, cells did not show any significant advantage over isolated enzymes in the synthesis of ethyl (R)-4-chloro-3-hydroxybutanoate although the velocity of the synthesis of ethyl (R)-4-chloro-3-hydroxybutanoate was slightly improved using whole-cell catalysts, giving an 80% substrate conversion in 120 min. Recombinant C. hydrogenoformans alcohol dehydrogenase was synthesized in A. adeninivorans and biochemically characterized. Enzyme showed high activity only with one substrate, ethyl benzoylformate. The A. adeninivorans and H. polymorpha cell catalysts synthesizing ChADH and BmGDH (Bacillus megaterium glucose dehydrogenase) were constructed and used in the synthesis of ethyl (R)-mandelate (reduction product of ethyl benzoylformate) with the enantiopurity of the reaction product being >98%. H. polymorpha catalysts were more effective in the synthesis than A. adeninivorans cells. The first were able to convert 93% of ethyl benzoylformate within 180 min and the latter were converting 94% of the substrate within 360 min. Re-use of non-immobilized cells and catalysts entrapped in Lentikat® was performed and the improvement of the stability of immobilized catalysts was reported. Space time yield of 3.07 mmol l-1 h-1 and 6.07 mmol l-1 h-1 was achieved with A. adeninivorans and H. polymorpha cell catalysts, respectively. Alcohol dehydrogenase 1 from A. adeninivorans was analyzed concerning the synthesis of enantiomerically pure chiral alcohols. The enzyme did not synthesize industrially attractive products. However, based on biochemical characterization enzyme plays a role in the synthesis of 1-butanol or ethanol and thereby it is of biotechnological interest.
Background: The association of polyomaviruses BK and JC with other opportunistic infections and graft-versus-host disease (GvHD) in allogeneic stem cell transplantation is controversially discussed. Methods: We conducted a retrospective study of 64 adult patients who received their first allogeneic stem cell transplantation between March 2010 and December 2014; the follow-up time was 2 years. Results: Acute leukemia was the most frequent underlying disease (45.3%), and conditioning included myeloablative (67.2%) and nonmyeloablative protocols (32.8%). All patients received 10 mg of alemtuzumab on day -2 (20 mg in case of mismatch) as GvHD prophylaxis. Twenty-seven patients (41.5%) developed cytomegalovirus (CMV) reactivation. BKPyV-associated hemorrhagic cystitis was diagnosed in 10 patients (15.6%). Other opportunistic infections caused by viruses or protozoa occurred rarely (<10%). There was no association of BKPyV or JCPyV with CMV reactivation, Epstein-Barr virus reactivation, human herpes virus 6, or parvovirus B19 infection requiring treatment. There was a significant correlation of BKPyV-associated hemorrhagic cystitis with toxoplasmosis (p = 0.013). Additionally, there was a significant link of simultaneous BKPyV and JCPyV viruria with toxoplasmosis (p = 0.047). BKPyV and JCPyV were not associated with GvHD, relapse, or death. Conclusion: We found no association of BKPyV or JCPyV with viral infections or GvHD. Only the correlation of both polyomaviruses with toxoplasmosis was significant. This is a novel and interesting finding.
Streptococcus pneumoniae (pneumococci), a human pathobiont, express and expose several proteinaceous colonization and virulence factors on its surface to facilitate on the one hand colonization of the upper respiratory tract and on the other hand pathogenesis in the host. In this study the interaction of two of such factors referred to as pneumococcal virulence factor A (PavA) and pneumococcal virulence factor B (PavB) and acting as microbial surface components recognizing adhesive matrix molecules (MSCRAMMs), was delineated with the two host matricellular proteins fibronectin (Fn) and vitronectin (Vn). Despite similarity in nomenclature, PavA and PavB represent two diverse pneumococcal proteins with respect to their structure and association with the pneumococcal surface. PavA is a non-classical surface protein (NCSP) with an ambiguous mode of secretion and anchorage while PavB is a characteristic MSCRAMM, anchored via sortase A to pneumococcal peptidoglycan. PavB has a signature of repetitive modules termed as streptococcal surface repeats (SSURE). Pneumococci preferentially interact with immobilized human Fn. In vitro cell culture adherence assays demonstrated that cell bound Fn facilitates the adherence of pneumococci to the host cells and this particular interaction is indifferent to host cell type and is species non-specific. Flow cytometry and immunoblot analyses further indicated the ability of pneumococci to interact with the soluble form of Fn in a dose-dependent but species non-specific manner. The molecular interaction of PavA and PavB (via its SSURE domains) with Fn was delineated further in detail via several direct protein-protein interaction approaches. Ligand overlay assays, surface plasmon resonance studies and SPOT peptide arrays demonstrated that PavA and PavB target at least 13 out of the 15 type III fibronectin domains located in the C-terminal part of Fn. Strikingly, both pneumococcal fibronectin-binding proteins (FnBPs) recognize similar peptides in targeted type III repeats. Structural comparisons revealed that the targeted type III epitopes cluster on the inner strands of both β-sheets forming the fibronectin domains. Importantly, synthetic peptides of FnIII1, FnIII5 or FnIII15 bind directly to FnBPs PavA and PavB, respectively. Thus, analysis of interaction of pneumococcal FnBPs PavA and PavB revealed a probable conserved and/or common pattern of molecular interaction with human Fn. In addition to Fn, pneumococcal PavB interacts with other host matricellular proteins such as human plasminogen (Plg) and human thrombospondin-1 (hTSP-1). Pneumococcal proteins such as PspC and PspC-like Hic have earlier been demonstrated to interact with hTSP-1 as well as human Vn, thereby depicting a redundant function as MSCRAMMs. In this study the role of PavB as a pneumococcal vitronectin binding protein (VnBP) was assessed. Flow cytometric analysis suggested PavB as VnBP, because strains deficient for PavB exhibited a significantly decreased ability to acquire vitronectin compared to wild-type pneumococci. When using a double knockout, deficient in expression of PavB and the VnBP PspC, the pneumococcal interaction with vitronectin was completely abolished. The direct protein-protein interaction assays such as far western ligand overlay, ELISA, and surface plasmon resonance indicated the interaction of SSURE domains with both soluble and immobilized Vn. However, the binding activity depends on the number of SSURE domains with five SSURE showing the highest binding activity to Vn. The interaction of PavB with Vn was charge dependent and heparin sensitive as analyzed by ELISA. The importance of the heparin binding domains of Vn in this interaction was further analyzed via direct protein-protein interaction approaches. Binding studies (far western ligand overlay, ELISA, and surface plasmon resonance) with truncated recombinant Vn fragments indicated that PavB targets the C-terminal heparin-binding domain (HBD3) of vitronectin, a characteristic shared with PspC, hence, suggesting a conserved molecular interaction of pneumococci with Vn. In addition to its function as an MSCRAMM, PavB has the capability to interact directly with host epithelial cells via an unknown cellular receptor. Thus, this study aimed to identify cellular receptor(s) for PavB. In vitro cell culture adherence and invasion assays confirmed that pneumococcal PavB is involved in promoting pneumococcal adherence to respiratory epithelial cells without employing any molecular bridge. The direct interaction between PavB and host epithelial cells was further confirmed via direct binding assays when using Cy5-labeled PavB and flow cytometric analysis. Strikingly, exogenously added human vitronectin competitively inhibited binding of PavB to respiratory epithelial cells. This observation led us to hypothesize that the major vitronectin receptor αvβ3 integrin acts as a potential receptor for PavB. This hypothesis was supported by functional blocking assays with monoclonal antibodies recognizing specific integrin subunits. The results revealed reduced binding of PavB in the presence of bound antibodies recognizing αv integrin indicating that PavB employs αvβ3 integrin as its direct receptor on eukaryotic cells. This was further confirmed via a direct binding assay of PavB to mouse embryonic fibroblasts (MEFs) where cells lacking αvβ3 demonstrated a marked decrease in binding to PavB. Although functional blocking assay and direct binding assay with MEFs supported the role of αvβ3 integrin as a direct adhesin for PavB, RNA interference of αv integrin in epithelial cells did not impair the binding of PavB in αv-knocked down cells in comparison to non-transfected cells. Finally, surface plasmon resonance (SPR) analysis indicated the direct interaction between pneumococcal PavB and recombinant αvβ3 integrin. In this study we report for the first time the interaction of a Gram-positive extracellular pathogen, namely Streptococcus pneumoniae, with one of the host ICAMs, namely the αvβ3 integrin. In conclusion, the present study analysed some of the aspects of molecular interaction of pneumococcal MSCRAMMs PavA and PavB with hFn and hVn. The hot spots of interaction on C-terminal FnIII repeats were delineated for PavA and PavB. HBD3 was revealed to be pivotal for PavB-Vn interaction. In addition the redundant role of pneumococcal PavB as an MSCRAMM was demonstrated. Furthermore this study successfully identifies a direct receptor for pneumococcal PavB, namely αvβ3 integrin. The mechanism and biological rationale of this newly identified interaction is a matter of debate and awaits further scientific analyses.